首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1561065

免疫組織化學市場規模、佔有率、成長分析、按應用、按最終用戶、按地區 - 行業預測，2024-2031

Immunohistochemistry Market Size, Share, Growth Analysis, By Application (Application Diagnostic applications, Research applications), By End User (Hospitals & Diagnostic Laboratories), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球免疫組化市場規模約29億美元，預測期間（2024-2031年）複合年成長率為7.4%，從2023年的31億美元上升，到2031年預計將達55億美元。

全球免疫組織化學 (IHC) 市場是更廣泛的生命科學和診斷市場中成長最快的部分，這主要是由癌症和其他慢性疾病的盛行率不斷上升所推動的。 IHC是識別組織抗原和生物標記的重要技術，廣泛應用於癌症診斷和監測、實現標靶治療、闡明疾病途徑。隨著個人化醫療的進步和疾病的早期檢測變得更加重要，對 IHC 技術的需求預計將迅速增加。該市場受益於領先公司持續的研發投資、新型生物標記的採用以及提高診斷準確性和效率的自動化 IHC 設備。市場按產品類型（抗體、試劑、儀器、套件）、應用（診斷、藥物測試、研究）和最終用戶（醫院、診斷實驗室、研究機構）進行細分。北美以強大的醫療基礎設施、高癌症發病率以及廣泛的研發活動而領先。緊隨其後的是歐洲和亞太地區，由於醫療保健成本上升、患者人數不斷增加以及對先進診斷技術的認知不斷增強，預計後者將快速成長。全球 IHC 市場競爭激烈，F. Hoffmann-La Roche AG、Danaher Corporation、Agilent Technologies 和 Thermo Fisher Scientific 等主要企業推動創新和市場擴張。

市場概況
抗體
- 類型
- 一抗
- 二抗
- 克隆性質
- 單株抗體
- 多株抗體
- 試劑
- 組織學染色
- 封閉血清/試劑
- 呈色受質
- 固定試劑
- 有機溶劑
- 蛋白水解酶
- 沖淡
- 其他試劑（抗原活化液、穩定劑、品管、封固液）
- 裝置
- 玻片染色系統
- 組織處理系統
- 幻燈片掃描儀
- 其他設備（數位病理學系統、組織學設備，例如自動蓋片機、視覺化設備（明視野、螢光顯微鏡）、切片機、石蠟分配器、玻片貼標機、組織微陣列）
- 套件
- 人類免疫組化試劑套件
- 動物免疫組化試劑套件

免疫組織化學市場：依應用分類

市場概況
診斷用途
- 癌症
- 感染疾病
- 自體免疫疾病
- 腎臟疾病
- 神經系統疾病
- 其他疾病（眼科、心血管、皮膚科、牙科疾病）
研究用途
- 藥物開發和測試
- 其他研究用途（幹細胞研究/發育生物學）
- 法醫學應用

免疫組織化學市場：依最終用戶分類

市場概況
醫院/診斷實驗室
學術機構/委外研發機構（CRO）
其他最終用戶（製藥公司、生物製藥公司、法醫學實驗室）

按地區分類的免疫組織化學市場規模

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

F. Hoffmann-La Roche Ltd.
Danaher Corporation
Agilent Technologies, Inc.
PHC Holdings Corporation
Thermo Fisher Scientific Inc.
Merck KGaA
Bio-Rad Laboratories, Inc.
Bio-Techne
Becton, Dickinson and Company
Takara Bio Inc.
Enzo Biochem Inc.
Sino Biological, Inc.
Sakura Finetek Japan Co., Ltd.
Cell Signaling Technology, Inc.
BIO SB
Miltenyi Biotec
OriGene Technologies, Inc.
EagleBio
Biocare Medical, LLC
Elabscience Bionovation Inc.
BioGenex
Diagnostic BioSystems Inc.
Histo-Line Laboratories
Rockland Immunochemicals, Inc.
Candor Bioscience GmbH
Genemed Biotechnologies, Inc.

簡介目錄

Product Code: SQMIG35H2224

Global Immunohistochemistry Market size was valued at around 2.9 billion in 2022 and is expected to rise from USD 3.1 billion in 2023 to reach a value of USD 5.5 billion by 2031, at a CAGR of 7.4% over the forecast period (2024-2031).

The Global Immunohistochemistry (IHC) Market is a rapidly growing sector within the broader life sciences and diagnostics markets, primarily driven by the increasing prevalence of cancer and other chronic diseases. IHC, a key technique for identifying tissue antigens and biomarkers, is widely used for diagnosing and monitoring cancer, enabling targeted therapy, and understanding disease pathways. With advancements in personalized medicine and a rising emphasis on early disease detection, the demand for IHC techniques is expected to surge. The market benefits from continuous R&D investments by major players, the introduction of novel biomarkers, and automated IHC instruments, which enhance diagnostic accuracy and efficiency. The market is segmented by product type (antibodies, reagents, equipment, kits), application (diagnostics, drug testing, research), and end-users (hospitals, diagnostic labs, research institutions). North America leads due to robust healthcare infrastructure, high cancer prevalence, and extensive R&D activities. Europe and Asia-Pacific follow, with the latter projected to witness the fastest growth due to rising healthcare expenditure, expanding patient pool, and increasing awareness of advanced diagnostic techniques. The global IHC market is highly competitive, with key players like F. Hoffmann-La Roche AG, Danaher Corporation, Agilent Technologies, and Thermo Fisher Scientific driving innovation and market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Immunohistochemistry Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Immunohistochemistry Market Segmental Analysis

Global Immunohistochemistry Market is segmented by Product, Application, and region. Based on Product, the market is segmented into Antibodies (Primary antibodies, Secondary antibodies) clonality (Monoclonal antibodies, Polyclonal antibodies), Reagents (Histological Stains, Blocking Sera and Reagents, Chromogenic Substrates, Fixation Reagents, Organic Solvents, Proteolytic Enzymes, Diluents, Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)), Equipment (Slide-staining Systems, Tissue Processing Systems, Slide Scanners, Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)), Kits (Human Immunohistochemistry Kits, Animal Immunohistochemistry Kits). Based on Application, the market is segmented into Application Diagnostic applications (Cancer, Infectious diseases, Autoimmune diseases, Nephrological diseases, Neurological diseases, Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases), Research applications (Drug Development and Testing, Other research applications (Stem Cell Research and Developmental Biology), and Forensic applications. Based on End User, the market is segmented into Hospitals & Diagnostic Laboratories, Academic Institutions & Contract Research Organizations (CROs), Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Immunohistochemistry Market

One of the major drivers of the Global Immunohistochemistry Market is the rising incidence of cancer worldwide. According to the World Health Organization (WHO), cancer is one of the leading causes of death globally, with millions of new cases diagnosed annually. Immunohistochemistry is a vital tool in oncology, providing crucial information for the diagnosis, prognosis, and selection of targeted therapies. With the increasing number of cancer cases, the demand for accurate and reliable diagnostic methods has surged, pushing the adoption of IHC techniques in clinical settings. Moreover, advancements in IHC, such as the development of new antibodies and detection systems, enhance the precision of cancer diagnostics, leading to better patient management and outcomes. As personalized medicine continues to gain traction, the role of IHC in selecting appropriate therapeutic strategies further reinforces its market growth.

Restraints in the Global Immunohistochemistry Market

The high cost of immunohistochemistry instruments and reagents is a significant restraint to the market's growth. IHC requires sophisticated equipment, including automated staining systems and advanced microscopes, which involve substantial capital investment. Additionally, the cost of reagents, such as antibodies and detection kits, can be high, especially when multiple tests are needed for comprehensive diagnosis. This makes IHC relatively expensive compared to other diagnostic techniques, limiting its adoption in regions with limited healthcare budgets or underdeveloped healthcare infrastructure. In emerging economies, the cost burden can be a significant barrier for smaller hospitals, clinics, and diagnostic labs that lack the financial resources to invest in advanced diagnostic technologies. Furthermore, the ongoing maintenance and operational costs associated with IHC instruments add to the overall expenses, creating a financial constraint for healthcare providers.

Market Trends of the Global Immunohistochemistry Market

The integration of automation and digital pathology in immunohistochemistry represents a significant trend shaping the market. Automated IHC instruments offer several advantages, such as reduced manual errors, enhanced reproducibility, and faster turnaround times, which are crucial for accurate and timely diagnosis. This trend is particularly important in high-throughput settings like hospitals and diagnostic laboratories. Furthermore, the integration of digital pathology with IHC allows for the digitization of slides, enabling remote analysis, collaboration, and AI-based image analysis. This advancement not only enhances diagnostic accuracy but also facilitates the efficient storage and retrieval of histopathological data, improving overall workflow efficiency. Leading market players are increasingly investing in developing automated IHC platforms integrated with digital pathology solutions, anticipating a robust adoption rate in the coming years due to their potential to transform pathology practices globally.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Ecosystem of the Market
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Study Analysis
Technology Analysis
Regulatory Analysis
Supply Chain Analysis
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Immunohistochemistry Market by Product

Market Overview
Antibodies
- Type
- Primary antibodies
- Secondary antibodies
- clonality
- Monoclonal antibodies
- Polyclonal antibodies
- Reagents
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Other Reagents (Antigen Retrieval Solutions, Stabilizers, Controls, And Mounting Solutions)
- Equipment
- Slide-staining Systems
- Tissue Processing Systems
- Slide Scanners
- Other Equipment (Digital Pathology Systems And Histology Equipment, Such As Automated Cover Slippers, Visualization Equipment (Bright-Field, Fluorescence Microscopes), Microtomes, Paraffin Dispensers, Slide Labelers, And Tissue Microarrays)
- Kits
- Human Immunohistochemistry Kits
- Animal Immunohistochemistry Kits

Immunohistochemistry Market by Application

Market Overview
Diagnostic applications
- Cancer
- Infectious diseases
- Autoimmune diseases
- Nephrological diseases
- Neurological diseases
- Other diseases (Ophthalmic, Cardiovascular, Dermatological, And Dental Diseases)
Research applications
- Drug Development and Testing
- Other research applications (Stem Cell Research And Developmental Biology)
- Forensic applications

Immunohistochemistry Market by End User

Market Overview
Hospitals & Diagnostic Laboratories
Academic Institutions & Contract Research Organizations (CROs)
Other end users (Pharmaceutical & Biopharma Companies, and Forensic Laboratories)

Immunohistochemistry Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PHC Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enzo Biochem Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sino Biological, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sakura Finetek Japan Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BIO SB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EagleBio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biocare Medical, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elabscience Bionovation Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioGenex
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diagnostic BioSystems Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Histo-Line Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rockland Immunochemicals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Candor Bioscience GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genemed Biotechnologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments